Kira Pharmaceuticals
Cambridge, United States · Founded 2017
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- kirapharma.com
- Last Round
- Series BJan 2021
- Rounds
- 3
About
Kira Pharmaceuticals is a clinical-stage global biotechnology company founded in 2017, headquartered in Cambridge, Massachusetts with offices in Suzhou and Shanghai, China, and Australia. The company is pioneering treatments for complement-mediated diseases using its proprietary LOGIC (Lead identification, Optimization and Attribute Generation, In-vivo Confirmation) platform. Since inception, Kira has built a robust pipeline of nine novel complement assets. The company's leadership team includes co-founders Wenru Song (President & Head of R&D) and Gonghua Pan, along with drug developers, protein engineers, and world-renowned complement biology experts.
Summary
Kira Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2017. Its most recent funding was a Series B round in Jan 2021. Investors include Quan Capital, RA Capital Management and Vivo Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...